MARKET

MXCT

MXCT

Maxcyte
NASDAQ
0.7600
+0.0065
+0.86%
After Hours: 0.7600 0 0.00% 18:36 04/09 EDT
OPEN
0.7538
PREV CLOSE
0.7535
HIGH
0.7619
LOW
0.7161
VOLUME
535.75K
TURNOVER
--
52 WEEK HIGH
2.955
52 WEEK LOW
0.6434
MARKET CAP
81.21M
P/E (TTM)
-1.8125
1D
5D
1M
3M
1Y
5Y
1D
Balanced Hold on MaxCyte: Weighing Repeated Revenue Misses and Soft 2026 Outlook Against Strong Cash Position and Emerging Platform Upside
TipRanks · 2d ago
Weekly Report: what happened at MXCT last week (0330-0403)?
Weekly Report · 3d ago
MaxCyte grants CFO Parmeet Ahuja 375,000 stock options under inducement plan
Reuters · 03/31 20:07
MAXCYTE REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 03/31 20:05
Analysts Offer Insights on Healthcare Companies: MoonLake Immunotherapeutics (MLTX), AbSci (ABSI) and MaxCyte (MXCT)
TipRanks · 03/30 11:02
Weekly Report: what happened at MXCT last week (0323-0327)?
Weekly Report · 03/30 09:17
MaxCyte Appoints New Chief Financial Officer Ahuja
TipRanks · 03/27 22:10
MaxCyte appoints Parmeet Ahuja CFO effective March 30, 2026; Douglas Swirsky transitions from the role
Reuters · 03/27 20:55
More
About MXCT
MaxCyte, Inc. is a commercial cell engineering company. The Company is focused on providing enabling platform technologies to advance the discovery, development and commercialization of cell therapeutics, including cell and gene therapies, and to support cell-based research and development. It has developed and commercialized its proprietary Flow Electroporation technology, which is used by biopharmaceutical companies in the complex engineering of a variety of cells. Its ExPERT platform is based on its Flow Electroporation technology, which has been designed to address this rapidly expanding cell therapy market and can be utilized across the continuum of the cell therapy sector, from discovery and development through commercialization of cell-based medicines. The ExPERT family of products includes four instruments, which are known as the ATx, STx, GTx and VLx, as well as a portfolio of proprietary related disposables and consumables.

Webull offers MaxCyte Inc stock information, including NASDAQ: MXCT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MXCT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MXCT stock methods without spending real money on the virtual paper trading platform.